Harvey Wong

4.5k total citations
100 papers, 2.4k citations indexed

About

Harvey Wong is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Harvey Wong has authored 100 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 37 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Harvey Wong's work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Stress Responses and Cortisol (9 papers). Harvey Wong is often cited by papers focused on Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Stress Responses and Cortisol (9 papers). Harvey Wong collaborates with scholars based in United States, Canada and France. Harvey Wong's co-authors include Louis Lin, Hank La, Stephen E. Gould, Cornelis E. C. A. Hop, Po‐Chang Chiang, Bruno Alicke, Frank‐Peter Theil, Adam R. Johnson, Edna F. Choo and Alberto Gobbi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Harvey Wong

98 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harvey Wong United States	29	1.0k	567	294	277	264	100	2.4k
Kristiina M. Huttunen Finland	27	1.3k 1.3×	678 1.2×	320 1.1×	96 0.3×	112 0.4×	112	2.9k
Mark J. Rose United States	23	794 0.8×	334 0.6×	195 0.7×	535 1.9×	239 0.9×	49	2.7k
M. David Percival Canada	36	1.4k 1.4×	520 0.9×	638 2.2×	193 0.7×	155 0.6×	68	3.1k
Andreas Reichel Germany	25	738 0.7×	755 1.3×	226 0.8×	61 0.2×	233 0.9×	88	2.6k
Jerome Hochman United States	30	1.0k 1.0×	1.0k 1.8×	72 0.2×	196 0.7×	618 2.3×	44	2.6k
Markos Leggas United States	24	1.0k 1.0×	1.1k 1.9×	165 0.6×	102 0.4×	153 0.6×	79	2.5k
J. Fred Nagelkerke Netherlands	32	1.4k 1.4×	647 1.1×	154 0.5×	538 1.9×	196 0.7×	87	3.6k
Stefano Fogli Italy	33	930 0.9×	747 1.3×	307 1.0×	153 0.6×	90 0.3×	94	2.6k
Amin A. Nomeir United States	28	834 0.8×	682 1.2×	327 1.1×	101 0.4×	483 1.8×	111	2.7k
Milton L. Brown United States	35	2.2k 2.2×	688 1.2×	1.1k 3.7×	181 0.7×	88 0.3×	109	3.8k

Countries citing papers authored by Harvey Wong

Since Specialization

Citations

This map shows the geographic impact of Harvey Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Wong more than expected).

Fields of papers citing papers by Harvey Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Wong. The network helps show where Harvey Wong may publish in the future.

Co-authorship network of co-authors of Harvey Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Wong. A scholar is included among the top collaborators of Harvey Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Wong. Harvey Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lerchen, Hans‐Georg, Beatrix Stelte‐Ludwig, Mélanie Héroult, et al.. (2023). Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors. Cancers. 15(17). 4381–4381. 8 indexed citations

Frigault, Melanie M., Harvey Wong, Beatrix Stelte‐Ludwig, et al.. (2023). Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription. Cancer Research Communications. 3(11). 2268–2279. 7 indexed citations

Diamond, Jennifer R., Valentina Boni, Emerson A. Lim, et al.. (2022). First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. Clinical Cancer Research. 28(7). 1285–1293. 30 indexed citations

Xie, Minli, Harvey Wong, Hank La, et al.. (2019). Cyclodextrin Reduces Intravenous Toxicity of a Model Compound. Journal of Pharmaceutical Sciences. 108(6). 1934–1943. 13 indexed citations

Chiang, Po‐Chang, et al.. (2018). Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans. Journal of Pharmaceutical Sciences. 107(7). 1798–1805. 14 indexed citations

Wong, Harvey, et al.. (2017). Physiologically Based Pharmacokinetic Modeling of Therapeutic Proteins. Journal of Pharmaceutical Sciences. 106(9). 2270–2275. 28 indexed citations

Wong, Harvey, Tonika Bohnert, Christopher R. Gibson, et al.. (2017). Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective. Drug Discovery Today. 22(10). 1447–1459. 22 indexed citations

Schutt, Leah, Jacqueline M. Tarrant, Michelle McDowell, et al.. (2016). Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats. Journal of Pharmacology and Experimental Therapeutics. 360(1). 226–238. 12 indexed citations

Ferl, Gregory Z., Frank‐Peter Theil, & Harvey Wong. (2015). Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini‐review on fundamental concepts and applications. Biopharmaceutics & Drug Disposition. 37(2). 75–92. 33 indexed citations

10.

Liu, Xingrong, Harvey Wong, Kimberly Scearce‐Levie, et al.. (2013). Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing. Drug Metabolism and Disposition. 41(7). 1319–1328. 17 indexed citations

11.

Wong, Harvey, Laurent Vernillet, Amy Peterson, et al.. (2012). Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor. Clinical Cancer Research. 18(11). 3090–3099. 65 indexed citations

12.

Wong, Harvey, Edna F. Choo, Bruno Alicke, et al.. (2012). Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response. Clinical Cancer Research. 18(14). 3846–3855. 96 indexed citations

13.

Wong, Harvey, Bruno Alicke, Kristina West, et al.. (2011). Pharmacokinetic–Pharmacodynamic Analysis of Vismodegib in Preclinical Models of Mutational and Ligand-Dependent Hedgehog Pathway Activation. Clinical Cancer Research. 17(14). 4682–4692. 96 indexed citations

14.

Deng, Yuzhong, Harvey Wong, Richard Graham, et al.. (2011). Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry. Journal of Chromatography B. 879(22). 2119–2126. 18 indexed citations

15.

Liu, Lichuan, et al.. (2011). Antiarthritis Effect of a Novel Bruton’s Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy. Journal of Pharmacology and Experimental Therapeutics. 338(1). 154–163. 65 indexed citations

16.

Liederer, Bianca M., Leonid M. Berezhkovskiy, Brian J. Dean, et al.. (2010). Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic–pharmacodynamic modelling ofN-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor. Xenobiotica. 41(4). 327–339. 7 indexed citations

17.

Wong, Harvey, Frank‐Peter Theil, Yong Cui, et al.. (2010). Interplay of Dissolution, Solubility, and Nonsink Permeation Determines the Oral Absorption of the Hedgehog Pathway Inhibitor GDC-0449 in Dogs: An Investigation Using Preclinical Studies and Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition. 38(7). 1029–1038. 17 indexed citations

18.

Wong, Harvey, Vincent Tong, K. Wayne Riggs, et al.. (2007). Kinetics of Valproic Acid Glucuronidation: Evidence for in Vivo Autoactivation. Drug Metabolism and Disposition. 35(8). 1380–1386. 11 indexed citations

19.

Li, Yu-Wen, Harvey Wong, Kate A. Ward, et al.. (2003). Receptor Occupancy of Nonpeptide Corticotropin-Releasing Factor 1 Antagonist DMP696: Correlation with Drug Exposure and Anxiolytic Efficacy. Journal of Pharmacology and Experimental Therapeutics. 305(1). 86–96. 47 indexed citations

20.

Wong, Harvey, Sanjeev Kumar, K. Wayne Riggs, & Dan Rurak. (2000). Pharmacokinetics and Renal Excretion of Diphenhydramine and its Metabolites, Diphenylmethoxyacetic Acid and Diphenhydramine‐N‐Oxide, in Developing Lambs. Journal of Pharmaceutical Sciences. 89(10). 1362–1370. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact